Cullen Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$313K Sell
1,437
-560
-28% -$124K ﹤0.01% 190
2025
Q4
$456K Buy
1,997
+750
+60% +$171K 0.01% 181
2025
Q3
$289K Hold
1,247
﹤0.01% 196
2025
Q2
$231K Sell
1,247
-1,095
-47% -$204K ﹤0.01% 194
2025
Q1
$491K Sell
2,342
-1,430
-38% -$278K 0.01% 156
2024
Q4
$670K Hold
3,772
0.01% 164
2024
Q3
$745K Hold
3,772
0.01% 141
2024
Q2
$647K Hold
3,772
0.01% 135
2024
Q1
$687K Buy
3,772
+298
+9% +$51.4K 0.01% 127
2023
Q4
$538K Buy
3,474
+234
+7% +$34.1K 0.01% 155
2023
Q3
$483K Sell
3,240
-192
-6% -$28.2K 0.01% 140
2023
Q2
$462K Hold
3,432
﹤0.01% 234
2023
Q1
$547K Sell
3,432
-88
-3% -$13.5K 0.01% 202
2022
Q4
$569K Hold
3,520
0.01% 154
2022
Q3
$472K Buy
3,520
+280
+9% +$40.2K 0.01% 220
2022
Q2
$496K Hold
3,240
0.01% 219
2022
Q1
$525K Sell
3,240
-369
-10% -$53.6K ﹤0.01% 216
2021
Q4
$489K Buy
+3,609
New +$426K ﹤0.01% 232
2021
Q3
Sell
-3,525
Closed -$397K 270
2021
Q2
$397K Buy
3,525
+9
+0.3% +$1.01K ﹤0.01% 226
2021
Q1
$381K Buy
+3,516
New +$376K ﹤0.01% 228

Other funds holding ABBV